CompletedNot Applicable

The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake

Turkey (Türkiye)59 participantsStarted 2026-01-09

Plain-language summary

Type of Study: This study was planned to be an observational study. Purpose of the Study: To evaluate the impact of HPV education given to women on their knowledge levels and HPV screening and vaccination.The main question\[s\] it aims to answer \[is/are\]: H1: There is a difference in the mean Human Papillomavirus (HPV) Knowledge Scale score between the intervention group women who participated in Human Papillomavirus (HPV) education and the control group women. H2: There is a difference between the intervention group women and the control group women in terms of their participation in HPV screening tests. H2: There is a difference between the intervention group women and the control group women in terms of their HPV vaccination status. Participants Participants will be assigned to a control and intervention group. Online training will be provided to the intervention group, and the results of the training will be reported.

Who can participate

Age range

18 Years – 35 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being female * Women aged 18-35 years * Ability to speak and understand Turkish at a level sufficient to communicate with the researcher * Having the technical equipment necessary to participate in a video interview * No diagnosis of HPV positivity * Not having received the HPV vaccine * Not having undergone HPV DNA/Pap smear testing in the past 5 years * No diagnosis of cervical cancer * Voluntary willingness to participate in the study * No diagnosis of a psychiatric disorder Exclusion Criteria: * Being male * Having severe physical or cognitive impairments that prevent completing the questionnaire * Being under 18 years of age or over 35 years of age * Inability to speak or understand Turkish * Lack of technical equipment to participate in a video interview * Having a diagnosis of HPV positivity * Having received the HPV vaccine * Having undergone HPV DNA/Pap smear testing in the past 5 years * Having a diagnosis of cervical cancer * Having a diagnosed psychiatric disorder Not agreeing to participate in the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in HPV Knowledge Score

Timeframe: Baseline (before intervention), 2 weeks after brochure delivery (first follow-up), and 8 weeks after the first follow-up (final follow-up)

Trial details

NCT IDNCT07320157

SponsorUfuk University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-23

View on ClinicalTrials.gov More HPV (Human Papillomavirus)-Associated trials